Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract Surgery

NCT07397936 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Disease (DED)
Cataract

Interventions

DRUG: Rebamipide 2% ophthalmic solution
DRUG: Diquafosol 3% ophthalmic solution
DRUG: Cyclosporine 0.05% ophthalmic solution

Sponsor

Samsung Medical Center